Edwards Lifesciences provided earnings guidance for the first quarter and full year of 2022. For the quarter, the company expects total sales to be between $1.27 billion and $1.35 billion.

For the full year, the company expects sales grow at a low double-digit rate to $5.5 billion to $6.0 billion.